Coherus BioSciences (CHRS) Reports Q1 Loss Per Share of $1.22

Coherus BioSciences (NASDAQ: CHRS) reported Q1 EPS of ($1.22), versus ($6.03) reported last year.

For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• Lument Finance Trust (LFT) Misses Q2 EPS by 17c